List view / Grid view
12 May 2015 | By Klyo Collaborative
Seven companies have voluntarily come together to form a new collaborative problem-solving group, aimed at assisting biopharmaceutical companies solve their most pressing lifecycle pipeline problems...
12 May 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of evofosfamide for the treatment of patients with advanced pancreatic cancer...
12 May 2015 | By Penn Pharma
Pharmaceutical manufacturer Penn Pharma a PCI company, today announced the successful installation of the Gerteis Mini-Pactor at its contained manufacturing facility...
12 May 2015 | By Victoria White
CPhI Istanbul (#cphiIstanbul), organised by UBM EMEA, will return to ICC Istanbul Congress Center, Istanbul, Turkey from 3 to 5 June 2015...
12 May 2015 | By Victoria White
Inovio Pharmaceuticals has initiated a Phase I trial to evaluate safety, tolerability and immune responses of its Ebola DNA immunotherapy...
12 May 2015 | By Victoria White
Takeda has announced that the first patient has been enrolled in the Phase 3 TOURMALINE-MM4 study of investigational oral ixazomib...
12 May 2015 | By Victoria White
The number of strokes occurring in men aged between 40 and 54 has rocketed by almost 50% in less than 15 years, according to the Stroke Association...
12 May 2015 | By Victoria White
GW Pharmaceuticals has commenced a Phase 3 clinical trial of Epidiolex (cannabidiol or CBD) for the treatment of Lennox-Gastaut syndrome (LGS)...
12 May 2015 | By Victoria White
Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company...
11 May 2015 | By Victoria White
Data from a post-hoc analysis of a Phase 3a trial demonstrates the weight-loss-dependent and independent effects of liraglutide 3 mg...
11 May 2015 | By Victoria White
SMC has accepted seven new medicines for use in NHS Scotland. Two of these medicines, Azerra and Zydelig, were considered under SMC’s PACE process...
11 May 2015 | By Victoria White
Boyds has joined CTD Holdings’ Clinical Programme Team along with Aptus Clinical and KJC Statistics to develop orphan drug Trappsol Cyclo with Accenture...
11 May 2015 | By Victoria White
The FDA has approved Avelox in the US to treat patients with plague, including pneumonic plague and septicemic plague...
11 May 2015 | By Victoria White
Transition Therapeutics has exclusively licensed worldwide rights to a novel small molecule drug candidate, TT701, from Eli Lilly and Company...
11 May 2015 | By Victoria White
WHO has declared Liberia free of Ebola transmission - forty-two days have passed since the last laboratory-confirmed case was buried...
